Skip to main
INGN
INGN logo

Inogen (INGN) Stock Forecast & Price Target

Inogen (INGN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

Inogen Inc. demonstrated a significant improvement in its financial performance, marked by an adjusted EBITDA margin increase of 1,850 basis points year-over-year, reaching (4.4%), and an operating margin enhancement of 2,400 basis points to (14.2%), exceeding market expectations. The business-to-business (B2B) segment showcased robust growth, rising by 28.1% to $50.7 million, driven by new customer acquisitions and expanded business with existing clients, alongside gains against competitors such as Philips. Additionally, the overall gross margin improved by 820 basis points year-over-year to 45.3%, reinforcing a positive financial trajectory for the company.

Bears say

Inogen Inc faces significant risks that contribute to a negative outlook, including slower-than-expected revenue growth, deteriorating profit margins, and potential market share loss to competitors. The company has reported a substantial decline in its direct-to-consumer (DTC) business, with DTC sales dropping 21.3% and rentals down 16.5%, leading to revised projections for adjusted EBITDA that indicate increasing losses over the next few years. Furthermore, the firm's high selling, general and administrative expenses, despite slight year-over-year improvement, suggest ongoing challenges in managing operational efficiency against a backdrop of flat or negative revenue growth expectations.

Inogen (INGN) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inogen (INGN) Forecast

Analysts have given Inogen (INGN) a Buy based on their latest research and market trends.

According to 7 analysts, Inogen (INGN) has a Buy consensus rating as of Jul 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $28.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $28.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inogen (INGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.